Skip to main content

Table 4 Different mutation detection rates among different study groups with different diagnostic methods

From: Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease

Ethnicity

No. of patients a

Mutation detection rate

Method

Reference

Caucasian

    

  American

202

89.1%

DHPLC, LR-PCR, DS

[1]

  American

183

63.0%

LR-PCR, NGS, targeted re-sequencing

[12]

  German

93

64.5%

LR-PCR, DS

[13]

  German

277

64.6%

DHPLC, LR-PCR, DS

[14]

  Czech

56

71.0%

Linkage analysis, LR-PCR, nested PCR with HRM, DS

[27]

  French

700

89.9%

LR-PCR, DS, QFM PCR or Array-CGH

[3]

Asian

    

  Chinese Hans

65

52.3%

DHPLC, LR-PCR, DS

[15]

  Taiwanese

46

65.0%

LR-PCR, DS, and Real time Q-PCR or MLPA

[16]

  Japanese

161

83.9%

LR-PCR, DS, and Q-PCR or MLPA

[17]

  Korean

20

90.0%

LR-PCR, DS, and MLPA

This study

  1. Abbreviations: DHPLC, denaturing high performance liquid chromatography; LR-PCR, long range-PCR; DS, direct sequencing; NGS, next-generation DNA sequencing; HRM, high resolution melting; QFM PCR, quantitative fluorescent multiplex PCR; Array-CGH, array-comparative genomic hybridization; Q-PCR, quantitative PCR; MLPA, multiplex ligation-dependent probe amplification.
  2. aNumber of unrelated patients in the study group.